NASDAQ:FENC Adherex Technologies (FENC) Stock Price, News & Analysis $8.66 +0.49 (+6.00%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$8.66 0.00 (0.00%) As of 08/22/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Adherex Technologies Stock (NASDAQ:FENC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Adherex Technologies alerts:Sign Up Key Stats Today's Range$8.10▼$8.7350-Day Range$7.72▼$9.2452-Week Range$3.96▼$9.42Volume166,030 shsAverage Volume58,881 shsMarket Capitalization$240.83 millionP/E RatioN/ADividend YieldN/APrice Target$13.33Consensus RatingBuy Company Overview Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product candidate is the Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was founded in 1996 and is based in Research Triangle Park, North Carolina. Read More Adherex Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks37th Percentile Overall ScoreFENC MarketRank™: Adherex Technologies scored higher than 37% of companies evaluated by MarketBeat, and ranked 730th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingAdherex Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageAdherex Technologies has only been the subject of 3 research reports in the past 90 days.Read more about Adherex Technologies' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Adherex Technologies are expected to decrease in the coming year, from ($0.11) to ($0.15) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Adherex Technologies is -20.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Adherex Technologies is -20.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Adherex Technologies' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.56% of the float of Adherex Technologies has been sold short.Short Interest Ratio / Days to CoverAdherex Technologies has a short interest ratio ("days to cover") of 16, which indicates bearish sentiment.Change versus previous monthShort interest in Adherex Technologies has recently decreased by 1.54%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAdherex Technologies does not currently pay a dividend.Dividend GrowthAdherex Technologies does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted5.56% of the float of Adherex Technologies has been sold short.Short Interest Ratio / Days to CoverAdherex Technologies has a short interest ratio ("days to cover") of 16, which indicates bearish sentiment.Change versus previous monthShort interest in Adherex Technologies has recently decreased by 1.54%, indicating that investor sentiment is improving. News and Social Media1.7 / 5News Sentiment-0.01 News SentimentAdherex Technologies has a news sentiment score of -0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 16 news articles for Adherex Technologies this week, compared to 2 articles on an average week.Search Interest1 people have searched for FENC on MarketBeat in the last 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Adherex Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $254,546.00 in company stock.Percentage Held by Insiders11.76% of the stock of Adherex Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions55.51% of the stock of Adherex Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Adherex Technologies' insider trading history. Receive FENC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Adherex Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address FENC Stock News HeadlinesInsider Selling: Adherex Technologies Inc. (NASDAQ:FENC) Director Sells 10,000 Shares of StockAugust 6, 2025 | insidertrades.comFennec Pharmaceuticals Inc. (FENC) Q2 2025 Earnings Call TranscriptAugust 19, 2025 | seekingalpha.comBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis. | Goldco Precious Metals (Ad)Wedbush Forecasts Weaker Earnings for Adherex TechnologiesAugust 19, 2025 | americanbankingnews.comWall Street Zen Upgrades Adherex Technologies (NASDAQ:FENC) to "Buy"August 19, 2025 | americanbankingnews.comAdherex Technologies (NASDAQ:FENC) Given New $14.00 Price Target at Craig HallumAugust 17, 2025 | americanbankingnews.comFennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business UpdateAugust 14, 2025 | globenewswire.comAdherex Technologies (NASDAQ:FENC) Cut to Hold at Wall Street ZenAugust 12, 2025 | americanbankingnews.comSee More Headlines FENC Stock Analysis - Frequently Asked Questions How have FENC shares performed this year? Adherex Technologies' stock was trading at $6.32 at the beginning of 2025. Since then, FENC shares have increased by 37.0% and is now trading at $8.66. How were Adherex Technologies' earnings last quarter? Adherex Technologies Inc. (NASDAQ:FENC) released its quarterly earnings results on Thursday, August, 14th. The company reported ($0.11) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by $0.05. The business earned $9.76 million during the quarter, compared to analysts' expectations of $9.52 million. Read the conference call transcript. How do I buy shares of Adherex Technologies? Shares of FENC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Adherex Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Adherex Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Alphabet (GOOG). Company Calendar Last Earnings8/14/2025Today8/23/2025Next Earnings (Estimated)11/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:FENC CIK1211583 Webwww.fennecpharma.com Phone919-636-4530Fax919-890-0490Employees10Year FoundedN/APrice Target and Rating Average Price Target for Adherex Technologies$13.33 High Price Target$14.00 Low Price Target$13.00 Potential Upside/Downside+54.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.42) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$440 thousand Net Margins-35.05% Pretax Margin-35.05% Return on EquityN/A Return on Assets-23.92% Debt Debt-to-Equity RatioN/A Current Ratio4.85 Quick Ratio4.97 Sales & Book Value Annual Sales$47.54 million Price / Sales5.07 Cash Flow$0.03 per share Price / Cash Flow252.97 Book Value($0.27) per share Price / Book-32.07Miscellaneous Outstanding Shares27,810,000Free Float24,543,000Market Cap$240.83 million OptionableOptionable Beta0.40 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:FENC) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adherex Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adherex Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.